Residual Risk From Remnant Cholesterol and Inflammation Despite Lipid-Lowering Therapy and Association With Incident Peripheral Artery Disease in Type 2 Diabetes.
BACKGROUND Despite guideline-recommended lipid-lowering therapy, patients with type 2 diabetes retain a significant residual risk for peripheral artery disease (PAD). The contributions of remnant cholesterol (RC) and systemic inflammation in this treated population, particularly beyond achieved low-density lipoprotein...